Navigation Links
Vasomedical Announces Financial Results for the Fourth Quarter and Year Ended 2012
Date:4/1/2013

uisitions in order to enhance our product lines. Most importantly, we have the capital resources needed to invest in our business and properly support future growth.  As of March 1, 2013 our cash and cash equivalents were $12.9 million," concluded Dr. Ma.

Three Months Ended December 31, 2012 Financial ResultsFor the three months ended December 31, 2012, revenue decreased 32.9% to $9.8 million, compared to $14.6 million for the three months ended December 31, 2011. The decrease in revenue is attributable to the Sales Representation segment, which recorded a lower commission rate in 2012 than in 2011. The lower commission rate was a direct result of a higher sales performance target preset early in the year and a flat domestic market for the products in 2012, despite a good performance by the VasoHealthcare sales team. According to our sales representation agreement with our partner, we earn a progressively higher commission rate as performance targets are met during the year, and the higher commission rate is applied retroactively to all booked orders in the year.  Therefore, we normally see higher commission revenue in the fourth quarter of the year when the relevant sales targets are met and the retroactive adjustments are made.  Consequently, the full impact of the lower commission rate in 2012 was also recorded in the fourth quarter results. Commission revenue from the retroactive adjustment in the fourth quarter 2012 was 64.8% lower than in the fourth quarter of 2011.

Gross profit for the fourth quarter of 2012 was $6.8 million, for a gross margin of 69.7%, compared to a gross profit of $10.5 million, for a gross margin of 71.8%, for the fourth quarter of 2011.

Selling, general and administrative (SG&A) expenses for the fourth quarter of 2012 were $6.3 million compared to $5.2 million for the same period last year. SG&A increased principally from higher sales and marketing expenses incurred in conjunction with the ex
'/>"/>

SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Vasomedical to Report Fourth Quarter and Year End 2012 Results on April 1, 2013
2. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
4. The International EECP Therapists Association and Vasomedical Announce Second Annual EECP Therapy Week
5. Vasomedical Common Stock Commences Trading on the OTCBB
6. Vasomedical Announces Financial Results for the Third Quarter of 2012
7. Vasomedical Named on Deloittes 2012 Technology Fast 500 List
8. Vasomedical Retains KCSA Strategic Communications as Corporate Communications Counsel
9. Cardiac Science announces definitive agreement to sell its Diagnostic Cardiology product line to Mortara Instrument, Inc.
10. BioLife Solutions Announces 2012 Full Year Results; 10th Consecutive Quarter of Record Revenue
11. Valeant Pharmaceuticals Announces Private Exchange Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... SAN DIEGO , July 29, 2014  Neurocrine ... that the Company will report its second quarter 2014 ... August 6, 2014.  Neurocrine will then host a live ... and provide a Company update Thursday morning, August 7, ... Time). Participants can access the live conference ...
(Date:7/29/2014)... TORONTO , July 29, ... ESAQ), an emerging pharmaceutical company exploring drug ... novel formulations and alternative dosage forms of ... its pharmaceutical development implementing its sub-micron platform technology.  ... drugs that will address indications in diabetes ...
(Date:7/29/2014)... LINCOLNSHIRE, Ill. , July 29, 2014  Sysmex ... equipment and information systems technology, will feature an exhibit ... (AACC) Annual Meeting and Clinical Lab Expo in ... 31, 2014. "We are extremely excited ... tremendous opportunity to interact with our customers and continue ...
Breaking Medicine Technology:Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 3
(Date:7/29/2014)... 2014 The Law Offices of Michael Cordova ... Hope, a non-profit organization providing grief camps for kids, teens, ... and suffering our clients experience from the death of a ... an organization like Stepping Stones of Hope, as they provide ... Stones of Hope also includes a monthly support group and ...
(Date:7/29/2014)... record the severity and regularity of their pain is ... , A new approach to the treatment of headaches, ... and is being led by Professor Paul Martin from ... He has developed an approach designed to enable people ... Learning to Cope with Triggers (LCT). , Using a ...
(Date:7/29/2014)... of cancer is to surgically remove the tumor. The ... surgeon may fail to extract the entire tumor, leading ... researchers at the University of Pennsylvania have established a ... in the patient, increasing the likelihood of a positive ... accumulates in cancerous tissues much more so than normal ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 A new ... during the 2014 Society for Cardiovascular Angiography and Interventions ... released this week. The videos review the benefits of ... services for the cardiac catheterization laboratory from the perspective ... the first video, Jane Kiah, MS, RN, Director of ...
(Date:7/29/2014)... boys with fragile X syndrome tend to decline ... of the inherited disorder to date has found. ... social and practical skills, including communication, socialization, and ... dressed. In this study, socialization emerged as a ... that it did not decline as much as ...
Breaking Medicine News(10 mins):Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3Health News:Socialization relative strength in fragile X longitudinal study 2
... up with a remarkable discovery. Scientists there, have found ... have added benefits. Sildenafil and other drugs that help to ... chemical messenger seem to help in unveiling cancer cells. ... by that the immune system. , The ...
... Dr. Reddy's Laboratories will launch a first-of-its-kind pill to ... it was announced Thursday. // ,The company ... New Zealand, for trials of the groundbreaking 'polypill' that ... to treat heart ailments. , ,India records nearly ...
... multi vitamin supplements have a healthier diet and lifestyle ... ,Researchers led by Lindsay Reaves of the University of ... weight, diet and health behaviour of over 2,500 US ... , ,The study, which appeared in the December ...
... areas as part of a government plan to reach healthcare ... government has released initial funds to the tune of Rs. ... in rural areas. ,According to a health ministry ... Health Mission (NRHM) scheme for 2006-07. ,The ...
... is admissible to Orthopaedically Handicapped/Paraplegic persons, Completely Blind, ... (both afflictions together in the same person). Except ... all classes to other categories. Deaf & Dumb ... and First Class. Concession is granted in all ...
... The American Dental association announced on the 9th of November, ... preparation of infant formulation. // ,The dentists are concerned ... might be disastrous as instead of protecting teeth it might ... lead to weakened bones and even bone cancer boys. ...
Cached Medicine News:Health News:Impotency Drugs Help to Unmask Cancer Cells 2Health News:Dr. Reddy's To Launch 'Polypill' For Treating Heart Disease 2
... The Hancock® II bioprosthesis from ... years of proven clinical experience. ... the freedom from structural valve ... and mitral bioprostheses is substantially ...
... bioprosthesis from Medtronic has more ... clinical experience. Worldwide clinical studies ... structural valve deterioration with Hancock® ... is substantially better than results ...
Attain Venogram Balloon Catheter....
... cardioverter defibrillators (ICDs) are designed to treat ... (SCD) due to arrhythmia. The size and ... is designed to facilitate ease of insertion ... 2 system incorporates Guidant's proprietary RHYTHM ID ...
Medicine Products: